BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 13, 2011
View Archived Issues
Viamet Pharmaceuticals' antifungals show promise in models of candidiasis and dermatophytosis
Read More
Preclinical and clinical data presented on AZD-5847 for tuberculosis
Read More
Takeda initiates phase I/II brentuximab vedotin study in Japan
Read More
Dosing complete in phase I trial of Antisense Therapeutics drug
Read More
Portuguese study identifies new biomarker for prognosis of ovarian cancer
Read More
Preclinical data support first-in-human trial of NBTXR-3
Read More
Merck Sharp & Dohme describes mode of action of antibacterial antibody CS-D7
Read More
SAVE-ONCO trial assesses semuloparin for thromboprophylaxis in patients with cancer
Read More
New York University prepares new anti-infective compounds
Read More
Kalypsys discloses novel histamine H4 receptor antagonists
Read More
New cysteine and cystine prodrugs presented by Promentis Pharmaceuticals
Read More
Vertex Pharmaceuticals launches Incivek in Canada
Read More
GSK provides funding for cancer research program
Read More
Researchers at Astellas synthesize new serotonin 5-HT2C receptor agonists
Read More
New muscarinic acetylcholine M1 receptor allosteric agonists claimed
Read More
Phase II study starts for Aduro BioTech's pancreatic cancer vaccines
Read More
FDA issues warning regarding leukemia drug Sprycel
Read More
UCSF receives NIH grant for antimalarial research
Read More
BioSante Pharmaceuticals reports phase III safety data on LibiGel
Read More
GlycoMimetics and Pfizer collaborate on GMI-1070 in sickle cell disease
Read More
Lilly files for additional approval for Strattera in Japan
Read More
Bayer and Onyx Pharmaceuticals restructure oncology collaboration
Read More
EMA recommends new orphan designation for 4SC-201
Read More
Kancera subsidiary discovers potent inhibitors of target schistosome protein
Read More
EMA confirms design of Intercell's planned phase II/III trial of Pseudomonas aeruginosa vaccine
Read More
